通过向Eis蛋白来克服Mycobacterium结核病中的氨基糖化物抗生素耐药性
Geethu S Kumar1, Kuldeep Sharma2, Richa Mishra3
1Centre for Development of Biomaterials and Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh 201310 India.
In silico pharmacology
|March 7, 2025
概括
这项研究选了3104种药物,以寻找针对增强细胞内生存 (Eis) 蛋白的新结核病治疗方法. 包括奥西默蒂尼布在内的五种药物显示出作为潜在的Eis抑制剂对抗药物耐药性的承诺.
科学领域:
- 计算机化药物发现.
- 分子建模分子建模
- 抗微生物耐药性研究的研究.
背景情况:
- 结核病 (TB) 仍然是一个关键的全球卫生问题,由耐药菌株加剧.
- 由于抗菌素耐药性日益增加,现有的治疗方法面临挑战.
- 药物再利用提供了一种具有成本效益的策略,用于识别新型治疗剂.
研究的目的:
- 通过计算选FDA批准的药物,以检测增强细胞内生存 (Eis) 蛋白的潜在抑制.
- 确定用于打击结核病耐药性的新药候选药物.
- 用分子动力学模拟来评估潜在的Eis抑制剂的结合稳定性.
主要方法:
- 使用计算方法对3104种FDA批准的药物对Eis蛋白进行查.
- 利用分子力学概括的Born表面积 (MM/GBSA) 来得分潜在的抑制剂.
- 执行500 ns分子动力学 (MD) 模拟,主要组件分析 (PCA) 和自由能量景观 (FEL) 分析,以评估复杂的稳定性.
主要成果:
- 五种药物,包括Isavuconazonium硫酸盐,Cefotiam Hexetil化物,恩扎斯塔乌林,沙尔布塔摩尔硫酸盐 (Albuterol) 和奥西默蒂尼布 (AZD9291),被确定为潜在的Eis抑制剂.
- MD模拟证实了这些药物-Eis复合物的稳定结合.
- PCA和FEL分析证实了已识别的复合物的结构稳定性.
结论:
- 已识别的药物显示出作为Eis抑制剂的显著潜力.
- 这些候选药物在结核病治疗中需要进一步的实验验证.
- 通过计算查重新定位药物是一种可行的策略,用于发现新的抗结核病药物.
相关概念视频
00:57Antibiotic Selection
52.1K
Overview
52.1K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:33Bacterial Transformation
55.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K